Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston blog main
boston top stories
4
×
eli lilly
genentech
4
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
clinical trials
fda
indiana blog main
indiana top stories
abbvie
astrazeneca
avapritinib
avexis
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
celgene
deals
detroit blog main
detroit top stories
investing
johnson & johnson
medullary thyroid cancer
microbiome
national
new york blog main
new york top stories
non-small cell lung cancer
novartis
pfizer
pralsetinib
raleigh-durham blog main
What
fda
4
×
drug
approval
bio
blueprint
cancer
medicines
news
regulatory
ret
roundup
address
approved
approves
august
biotech
busy
candidate
carries
certain
companies
currently
days
decisions
designed
devices
digital
disease
drugs
epidemic
fatty
frenzied
genetic
growing
known
latest
led
legacy
liver
marketing
Language
unset
Current search:
genentech
×
biotech
×
" boston top stories "
×
fda
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More